An epidemic of redundant meta‐analyses
- 4 March 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 19 (5), 1299-1306
- https://doi.org/10.1111/jth.15280
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysisJournal of Thrombosis and Thrombolysis, 2019
- Editor's Choice – A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with CancerEuropean Journal of Vascular and Endovascular Surgery, 2019
- Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysisPLOS ONE, 2019
- Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysisThrombosis Research, 2018
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Journal of Clinical Oncology, 2018
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysisThrombosis Research, 2018
- Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismThe New England Journal of Medicine, 2018
- The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analysesThe Milbank Quarterly, 2016
- Tranexamic acid in hip fracture surgery: a randomized controlled trialBritish Journal of Anaesthesia, 2009
- Presentation The emergence of a new species: The professional meta-analystJournal of Clinical Epidemiology, 1994